AstraZeneca PLC (LON:0A4J)

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of GBP 200.04 billion. The enterprise value is 218.31 billion.

Market Cap	200.04B
Enterprise Value	218.31B

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	Aug 8, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	80.48%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 28.61 and the forward PE ratio is 16.93.

PE Ratio	28.61
Forward PE	16.93
PS Ratio	4.63
PB Ratio	5.85
P/TBV Ratio	n/a
P/FCF Ratio	21.24
P/OCF Ratio	17.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.14, with an EV/FCF ratio of 23.18.

EV / Earnings	31.22
EV / Sales	5.05
EV / EBITDA	14.14
EV / EBIT	18.46
EV / FCF	23.18

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.71.

Current Ratio	0.88
Quick Ratio	0.69
Debt / Equity	0.71
Debt / EBITDA	1.57
Debt / FCF	2.58
Interest Coverage	12.24

Financial Efficiency

Return on equity (ROE) is 21.67% and return on invested capital (ROIC) is 13.17%.

Return on Equity (ROE)	21.67%
Return on Assets (ROA)	9.07%
Return on Invested Capital (ROIC)	13.17%
Return on Capital Employed (ROCE)	19.79%
Revenue Per Employee	458,568
Profits Per Employee	74,149
Employee Count	94,300
Asset Turnover	0.53
Inventory Turnover	1.59

Taxes

In the past 12 months, AstraZeneca has paid 1.51 billion in taxes.

Income Tax	1.51B
Effective Tax Rate	17.79%

Stock Price Statistics

The stock price has increased by +9.37% in the last 52 weeks. The beta is 0.18, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+9.37%
50-Day Moving Average	69.95
200-Day Moving Average	75.33
Relative Strength Index (RSI)	62.59
Average Volume (20 Days)	7,451

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of GBP 43.24 billion and earned 6.99 billion in profits. Earnings per share was 4.48.

Revenue	43.24B
Gross Profit	36.00B
Operating Income	11.84B
Pretax Income	8.51B
Net Income	6.99B
EBITDA	15.19B
EBIT	11.84B
Earnings Per Share (EPS)	4.48

Balance Sheet

The company has 6.09 billion in cash and 24.30 billion in debt, giving a net cash position of -18.21 billion.

Cash & Cash Equivalents	6.09B
Total Debt	24.30B
Net Cash	-18.21B
Net Cash Per Share	n/a
Equity (Book Value)	34.20B
Book Value Per Share	22.01
Working Capital	-3.06B

Cash Flow

In the last 12 months, operating cash flow was 11.26 billion and capital expenditures -1.85 billion, giving a free cash flow of 9.42 billion.

Operating Cash Flow	11.26B
Capital Expenditures	-1.85B
Free Cash Flow	9.42B
FCF Per Share	n/a

Margins

Gross margin is 83.26%, with operating and profit margins of 27.38% and 16.17%.

Gross Margin	83.26%
Operating Margin	27.38%
Pretax Margin	19.68%
Profit Margin	16.17%
EBITDA Margin	35.13%
EBIT Margin	27.38%
FCF Margin	21.78%

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 1.07%.

Dividend Per Share	0.88
Dividend Yield	1.07%
Dividend Growth (YoY)	3.74%
Years of Dividend Growth	n/a
Payout Ratio	52.89%
Buyback Yield	0.08%
Shareholder Yield	1.15%
Earnings Yield	3.50%
FCF Yield	4.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 8, 1998. It was a forward split with a ratio of 3.

Last Split Date	Apr 8, 1998
Split Type	Forward
Split Ratio	3

Scores

AstraZeneca has an Altman Z-Score of 2.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	7